Christian Jorgensen Selected Research

Uveitis

1/2018	Poor efficacy of TNF inhibitors in non-radiographic axial spondyloarthritis in the absence of objective signs: A bicentric retrospective study.
5/2017	Association of TRAF1-C5 with risk of uveitis in juvenile idiopathic arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christian Jorgensen Research Topics

Disease

36	Rheumatoid Arthritis 01/2020 - 02/2002
20	Inflammation (Inflammations) 03/2020 - 11/2002
17	Arthritis (Polyarthritis) 01/2021 - 10/2004
15	Osteoarthritis 01/2021 - 10/2004
14	Experimental Arthritis 02/2016 - 07/2002
11	Neoplasms (Cancer) 01/2022 - 11/2003
10	Rheumatic Diseases (Rheumatism) 01/2021 - 03/2011
9	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 05/2004
6	Systemic Scleroderma (Systemic Sclerosis) 10/2021 - 01/2016
5	Hypoxia (Hypoxemia) 01/2021 - 08/2015
5	Fibrosis (Cirrhosis) 01/2018 - 01/2016
4	Infections 01/2021 - 12/2005
4	Wounds and Injuries (Trauma) 01/2021 - 12/2013
3	Pain (Aches) 01/2020 - 07/2016
3	Neoplasm Metastasis (Metastasis) 10/2009 - 04/2007
2	Adult-Onset Still's Disease 01/2019 - 11/2014
2	Uveitis 01/2018 - 05/2017
2	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2016 - 09/2015
2	Breast Neoplasms (Breast Cancer) 10/2015 - 11/2008
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2015 - 02/2013
2	Synovitis 11/2012 - 10/2012
2	Carcinoma (Carcinomatosis) 10/2009 - 06/2008
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	COVID-19 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Ischemia 01/2021
1	Infectious Arthritis (Septic Arthritis) 11/2019
1	Rheumatic Fever (Acute Articular Rheumatism) 11/2019
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2019
1	Central Nervous System Diseases (CNS Diseases) 01/2019
1	Musculoskeletal Diseases (Musculoskeletal Disease) 11/2018
1	Connective Tissue Diseases (Connective Tissue Disease) 10/2018
1	Heart Diseases (Heart Disease) 10/2018
1	Hypertrophy 06/2018
1	Osteoporosis 06/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	Sacroiliitis 01/2018
1	Multiple Sclerosis 01/2018
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018

Drug/Important Bio-Agent (IBA)

12	CytokinesIBA 01/2021 - 07/2002
11	Therapeutic UsesIBA 01/2021 - 06/2006
10	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2011
10	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2011 - 11/2002
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2011
7	tocilizumab (atlizumab)FDA Link 01/2019 - 07/2011
6	Small Interfering RNA (siRNA)IBA 01/2021 - 06/2006
5	Monoclonal AntibodiesIBA 01/2022 - 02/2002
5	Biological ProductsIBA 01/2019 - 04/2010
5	CollagenIBA 01/2018 - 12/2010
5	Interleukin-10 (Interleukin 10)IBA 10/2012 - 07/2002
4	Pharmaceutical PreparationsIBA 09/2020 - 05/2004
4	EnzymesIBA 01/2020 - 04/2017
3	AntibodiesIBA 03/2020 - 12/2012
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 08/2015
3	Oxygen (Dioxygen)IBA 01/2020 - 08/2015
3	Rituximab (Mabthera)FDA Link 01/2017 - 10/2012
3	Collagenases (Collagenase)FDA Link 01/2016 - 11/2012
3	Interleukin-6 (Interleukin 6)IBA 12/2015 - 02/2014
3	ChemokinesIBA 10/2015 - 11/2008
2	SenotherapeuticsIBA 01/2021 - 06/2018
2	Immunosuppressive Agents (Immunosuppressants)IBA 03/2020 - 04/2008
2	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2020 - 03/2018
2	Antirheumatic Agents (DMARD)IBA 01/2019 - 08/2010
2	Ion Channels (Ion Channel)IBA 01/2018 - 09/2016
2	Tumor Necrosis Factor InhibitorsIBA 01/2018 - 07/2014
2	RNA (Ribonucleic Acid)IBA 01/2017 - 01/2011
2	ofatumumab FDA Link 01/2016 - 08/2010
2	Estrogen ReceptorsIBA 10/2015 - 11/2008
2	Proteins (Proteins, Gene)FDA Link 07/2015 - 09/2010
2	MicellesIBA 05/2015 - 01/2009
2	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2015 - 02/2013
2	AntigensIBA 05/2014 - 10/2004
2	Interleukin-8 (Interleukin 8)IBA 02/2014 - 11/2008
2	Dinoprostone (PGE2)FDA Link 05/2013 - 12/2010
2	InterferonsIBA 02/2013 - 01/2008
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2010 - 11/2002
2	Tetracycline (Achromycin)FDA LinkGeneric 12/2002 - 07/2002
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	OligomycinsIBA 01/2021
1	HydrogelsIBA 09/2020
1	AutoantibodiesIBA 03/2020
1	UbiquitinIBA 01/2020
1	LipidsIBA 01/2020
1	OxygenasesIBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2019
1	baricitinibIBA 01/2019
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2018
1	Chloroquine (Aralen)FDA LinkGeneric 10/2018
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 03/2018
1	C-Reactive ProteinIBA 01/2018

Therapy/Procedure

28	Therapeutics 10/2021 - 12/2002
4	Injections 01/2018 - 09/2006
4	Biological Therapy 11/2014 - 08/2008
3	Immunomodulation 01/2018 - 10/2004
2	Precision Medicine 12/2019 - 01/2018
2	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2016 - 10/2006
2	Immunotherapy 01/2008 - 10/2004
1	Drug Therapy (Chemotherapy) 01/2020
1	Hepatectomy 01/2018